ARQ Arq, Inc.
Miscellaneous Chemical Products · Nasdaq · SEC CIK 1515156 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.3%
TTM net income YoY-966.8%
TTM EPS YoY-972.7%
Revenue 3-yr CAGR10.2%
Net income 3-yr CAGR—
Margins
Gross margin32.1%
Operating margin-38.8%
Net margin-39.0%
FCF margin1.1%
EBITDA margin-28.7%
Returns
ROE-25.4%
ROA-19.3%
ROIC (approx.)-18.5%
Asset turnover0.50x
Leverage & solvency
Liabilities / assets26.4%
Debt / equity0.16x
Current ratio1.20x
Interest coverage-17.76x
Cash quality & payout
Operating cash flow / net income-0.10x
Accruals ratio-21.2%
Payout ratio—
Capex / revenue2.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $120.34M | $108.96M |
| Cost of revenue | $86.80M | $69.52M |
| Gross profit | $33.53M | $39.44M |
| R&D expense | $7.34M | $4.05M |
| SG&A expense | $22.55M | $28.70M |
| Operating income | -$52.96M | -$1.96M |
| Interest expense | $2.45M | $3.26M |
| Pretax income | -$52.60M | -$5.27M |
| Income tax | $12,000 | -$164,000 |
| Net income | -$52.61M | -$5.11M |
| EBITDA | -$41.21M | $6.63M |
| EPS (basic) | -1.27 | -0.14 |
| EPS (diluted) | -1.27 | -0.14 |
| Weighted avg. shares (diluted) | 41.52M | 36.05M |
| Balance sheet | ||
| Cash & equivalents | $6.57M | $22.23M |
| Receivables | $14.98M | $14.88M |
| Inventory | $15.89M | $19.31M |
| Current assets | $43.85M | $52.36M |
| PP&E, net | $143.15M | $178.56M |
| Intangibles | $570,000 | $7.57M |
| Total assets | $230.97M | $284.37M |
| Current liabilities | $42.30M | $44.65M |
| Short-term debt | $20.01M | $15.45M |
| Long-term debt | $8.45M | $9.37M |
| Total debt | $28.46M | $24.82M |
| Total liabilities | $62.62M | $67.09M |
| Shareholders' equity | $168.36M | $218.61M |
| Net debt | $21.89M | $2.59M |
| Shares outstanding | 42.73M | 42.02M |
| Cash flow statement | ||
| Operating cash flow | -$2.73M | $10.48M |
| Capital expenditure | $8.58M | $85.17M |
| Free cash flow | -$11.31M | -$74.69M |
| Investing cash flow | -$8.16M | -$85.07M |
| Financing cash flow | $3.70M | $42.68M |
| Depreciation & amortization | $11.75M | $8.59M |
| Stock-based compensation | $3.36M | $2.71M |
Free plan shows the latest 2 periods; Pro shows all 14 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.